Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap USD M358Revenue (TTM) USD M46.4Net Margin (%)-197.5Altman Z-Score-9.2
Enterprise Value USD M323EPS (TTM) USD -0.4Operating Margin %-182.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.5Pre-tax Margin (%)-197.8Higher ROA y-yY
Price/Book10510-y EBITDA Growth Rate %-28.1Quick Ratio2.1Cash flow > EarningsY
Price/Sales7.75-y EBITDA Growth Rate %-24.0Current Ratio2.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-37.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-240.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M243ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARNA is held by these investors:



ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
White Christine AnnaDirector 2016-06-13Sell18,728$1.99-26.13view
WOODS RANDALL EDirector 2015-03-30Sell76,268$4.49-67.26view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-70.6view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-76.52view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-73.22view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-74.87view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-74.87view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-79.15view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-79view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-76.7view

Quarterly/Annual Reports about ARNA:

News about ARNA:

Articles On GuruFocus.com
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
(ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW Apr 07 2013 
WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC Oct 07 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 
Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
Vivus Could Rocket on Success of Qnexa Apr 13 2012 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Arena Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
Arena Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2010 

More From Other Websites
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARNA-US :... Feb 22 2017
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 14 2017
Arena Pharmaceuticals Appoints Three New Members to Board of Directors Feb 14 2017
Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th Congress of European... Feb 09 2017
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US :... Jan 30 2017
Puma (PBYI) Expands Study Cohort for Lead Candidate PB272 Jan 09 2017
Vertex Pharma Issues Disappointing 2017 Orkambi Outlook Jan 09 2017
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 06 2017
Arena Pharmaceuticals Dumps Belviq Weight Loss Drug Jan 06 2017
Genocea Stock Up on Positive Genital Herpes Infections Data Jan 06 2017
Biogen Licenses Amunix's XTEN Technology for Factor IX Drug Jan 06 2017
Arena, Eisai Modify Marketing & Supply Agreement for Belviq Jan 05 2017
Evoke Diabetic Gastroparesis Drug Gimoti Positive in Phase III Jan 05 2017
Allergan (AGN) Liletta sNDA Accepted for Review in the U.S. Jan 05 2017
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US :... Jan 05 2017
Eisai Acquires All Global Development and Marketing Rights for Chronic Weight Management Treatment... Jan 04 2017
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 04 2017
Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally Jan 04 2017
Clovis Declares Pricing of Upsized Offering of Common Stock Jan 04 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)